Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments
Crossref DOI link: https://doi.org/10.1186/s42358-024-00401-y
Published Online: 2024-08-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tavakoli, Gita Manzari
Yazdanpanah, Niloufar
Rezaei, Nima http://orcid.org/0000-0002-3836-1827
Text and Data Mining valid from 2024-08-21
Version of Record valid from 2024-08-21
Article History
Received: 1 December 2023
Accepted: 7 August 2024
First Online: 21 August 2024
Declarations
:
: Not applicable.
: The authors declare that they have no competing interests.